Seeking Alpha

ILMN
Illumina, Inc.

5/26/2012, 11:25 AM ET
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
ILMN Market Currents more »
  • May 7 Illumina (ILMN +2.1%) moves up after Credit Suisse upgraded the shares to Outperform earlier today, based on improved prospects for sequential growth over the short-term, primarily from its consumable pull-through and the MiSeq launch. The firm also raises its price target to $55 from $48.
    Comment!
    [Healthcare, On the Move]
ILMN in Focus more »
ILMN News more »
ILMN Instablog posts more »
  • Barchart Morning Call 4/23
    Mon, Apr 23 • Jim Van Meerten • Comment!
  • Illumina CEO Has Year To Top Roche's $6.7 Billion Offer-Bloomberg
    Fri, Apr 20 • Tim Travis • Comment!
  • The Seemingly Random Nature of our Investment Strategy
    Tue, Apr 17 • New Low Observer • 7 Comments
  • Obamacare: Medical Management Without Medicine
    Mon, Apr 9 • Charles Margolis • Comment!
  • The Hepatitis C Gold Rush - Looking For The Right Fit For Idenix's Drug IDX184
    Tue, Feb 14 • EXPstocktrader • 1 Comment
Write a post on ILMN
ILMN StockTalks
ILMN vs. ETF Alternatives
Company Description

We are a leading developer, manufacturer, and marketer of integrated systems for the analysis of genetic variation and biological function. We were incorporated in California in April 1998 and reincorporated in Delaware in July 2000. Our principal executive offices are located at 9885 Towne... More

Sector: Healthcare
Industry: Biotechnology
Country: United States